Two JAMA Surgery studies examine bariatric surgery for type 2 diabetes treatment

June 4, 2014, The JAMA Network Journals

Roux-en-Y gastric bypass surgery resulted in the greatest average weight and appears to be the best treatment for type 2 diabetes mellitus (T2DM) compared to gastric banding and lifestyle intervention in a clinical trial that also highlights the challenges to completing a larger trial with patients with a body mass index (BMI) of 30 to 40.

Questions remain unanswered about the role of bariatric surgery in the treatment of T2DM, including the safety, efficacy and economic impact. Answers could come in a large, multicenter randomized clinical trial (RCT), but such a trial would be costly and potentially difficult to execute.

The authors report the results of an RCT examining the feasibility of a larger study and comparing the effectiveness of two types of bariatric surgery Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable (LAGB) and an intensive lifestyle weight-loss intervention in adults with a BMI of 30 to 40 and T2DM. While 667 adults were assessed for eligibility, the trial included 69 participants (24 assigned to receive RYGB, 22 to LAGB and 23 to the ).

Patients who had RYGB had the greatest weight change (-27 percent) compared with LAGB and the lifestyle intervention (-17.3 percent and -10.2 percent, respectively). No participants in the lifestyle intervention achieved partial or complete remission of T2DM at 12 months; 50 percent of the patients in the RYGB group had partial remission and 17 percent achieved complete remission, compared with the LAGB group where 27 percent of patients had partial T2DM remission and 23 percent had complete remission.

"This study highlights several potential challenges to successfully completing a larger RCT for treatment of T2DM and obesity in patients with a BMI of 30 to 40, including the difficulties associated with recruiting and randomizing patients to surgical vs. nonsurgical interventions." Anita P. Courcoulas, M.D., M.P.H., of the University of Pittsburgh Medical Center, and colleagues write in their JAMA Surgery paper.

Roux-en-Y Gastric Bypass Means Greater Weight Loss, Other Improvements in Obese Patients

Obese patients type 2 diabetes (T2DM) who underwent Roux-en-Y (RYGB) surgery had greater weight loss and other sustained improvements compared with intensive medical/weight management of the disease in a clinical trial that further confirmed the feasibility of conducting a larger trial to compare bariatric surgery with other interventions.

Data support as a therapeutic strategy to manage T2DM.

Authors tested the feasibility of conducting a larger trial to determine the long-term effect of RYGB compared with intensive medical/weight management in ( 30 to 42) with T2DM. The trial analyzed data from 38 participants (19 in the RYGB group and 19 in the medical/weight management intervention).

At one year, more patients in the RYGB group than the medical/weight management group (58 percent vs. 16 percent, respectively) achieved HbA 1c below 6.5 percent and fasting glucose below 126 mg/dL. Other outcomes, including HbA 1c , weight, waist circumference, fat mass, lean mass, blood pressure and triglyceride levels, decreased more and high-density lipoprotein cholesterol increased more after RYGB than the nonsurgical intervention.

"These differences may help inform therapeutic decisions for diabetes and weight loss strategies in obese patients with type 2 diabetes until larger randomized are performed." says Florencia Halperin, M.D., of the Brigham and Women's Hospital, Boston, and colleagues in the same JAMA Surgery issue.

Explore further: Substantial weight loss for severely obese individuals three years after bariatric surgery

More information: JAMA Surgery. Published online June 4, 2014. DOI: 10.1001/jamasurg.2014.467
JAMA Surgery. Published online June 4, 2014. DOI: 10.1001/jamasurg.2014.514

Related Stories

Substantial weight loss for severely obese individuals three years after bariatric surgery

November 4, 2013
In 3-year follow-up after bariatric surgery, substantial weight loss was observed among individuals who were severely obese, with most of the change occurring during the first year; however, there was variability in the amount ...

Over long-term, gastric bypass surgery associated with higher rate of diabetes remission

September 18, 2012
Severely obese patients who had Roux-en-Y gastric bypass surgery had significant weight loss that was sustained for an average of 6 years after the surgery and also experienced frequent remission and lower incidence of diabetes, ...

Decrease in fat cell volume improves insulin sensitivity

May 13, 2014
(HealthDay)—For obese women, a reduction in fat cell volume after bariatric surgery is strongly associated with improvement in insulin sensitivity, with the peak incidence seen among older women, according to a study published ...

Gastric bypass surgery may help manage diabetes risk factors

June 4, 2013
Among mild to moderately obese patients with type 2 diabetes, adding gastric bypass surgery to lifestyle and medical management was associated with a greater likelihood of improved levels of metabolic risk factors such as ...

New scoring system predicts likelihood of diabetes remission after weight-loss surgery

September 12, 2013
US scientists have developed a simple scoring system (DiaRem), based on four readily available preoperative patient characteristics, that can predict which candidates for gastric bypass surgery are likely to achieve diabetes ...

Little difference found between self-reported and measured weights following bariatric surgery

November 4, 2013
In an analysis that included nearly 1,000 patients, self-reported weights following bariatric surgery were close to measured weights, suggesting that self-reported weights used in studies are accurate enough to be used when ...

Recommended for you

Drug may help surgical patients stop opioids sooner

December 13, 2017
(HealthDay)—Opioid painkillers after surgery can be the first step toward addiction for some patients. But a common drug might cut the amount of narcotics that patients need, a new study finds.

Children best placed to explain facts of surgery to patients, say experts

December 13, 2017
Getting children to design patient information leaflets may improve patient understanding before they have surgery, finds an article in the Christmas issue of The BMJ.

Burn victim saved by skin grafts from identical twin (Update)

November 23, 2017
A man doomed to die after suffering burns across 95 percent of his body was saved by skin transplants from his identical twin in a world-first operation, French doctors said Thursday.

Is a common shoulder surgery useless?

November 21, 2017
(HealthDay)—New research casts doubt on the true effectiveness of a common type of surgery used to ease shoulder pain.

Study shows electric bandages can fight biofilm infection, antimicrobial resistance

November 6, 2017
Researchers at The Ohio State University Wexner Medical Center have shown - for the first time - that special bandages using weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic ...

Obesity increases incidence, severity, costs of knee dislocations

November 3, 2017
A new study of more than 19,000 knee dislocation cases in the U.S. between 2000 and 2012 provides a painful indication of how the nation's obesity epidemic is changing the risk, severity and cost of a traumatic injury.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.